Jazz Pharmaceuticals PLC Working Capital to Net Assets Ratio
Jazz Pharmaceuticals PLC working capital to net assets ratio. Jazz Pharmaceuticals PLC (JAZZ) has a Working Capital to Net Assets ratio of 51.6% as of March 2026. Working capital of $2.34 Billion (current assets of $4.58 Billion minus current liabilities of $2.25 Billion) is measured against net assets of $4.53 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Jazz Pharmaceuticals PLC (2005–2025)
Working capital to net assets ratio of Jazz Pharmaceuticals PLC from 2005 to 2025. This chart shows how Jazz Pharmaceuticals PLC's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2005 to 2025. As of March 2026, the ratio stands at 51.6%, reflecting working capital of $2.34 Billion against net assets of $4.53 Billion USD. Explore JAZZ strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Jazz Pharmaceuticals PLC Working Capital to Net Assets Ratio by Year (2005–2025)
Jazz Pharmaceuticals PLC working capital to net assets ratio by year from 2005 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Jazz Pharmaceuticals PLC from 2005 to 2025, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Jazz Pharmaceuticals PLC balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 44.5% | $1.92 Billion | $4.32 Billion | $4.17 Billion | $2.24 Billion | ▼ -43.2 pp |
| 2024 | 87.7% | $3.59 Billion | $4.09 Billion | $4.63 Billion | $1.04 Billion | ▲ +36.9 pp |
| 2023 | 50.8% | $1.90 Billion | $3.74 Billion | $3.44 Billion | $1.54 Billion | ▼ -3.4 pp |
| 2022 | 54.2% | $1.67 Billion | $3.09 Billion | $2.61 Billion | $933.19 Million | ▲ +8.8 pp |
| 2021 | 45.4% | $1.80 Billion | $3.97 Billion | $2.61 Billion | $809.30 Million | ▼ -14.3 pp |
| 2020 | 59.7% | $2.19 Billion | $3.66 Billion | $2.84 Billion | $653.75 Million | ▲ +19.0 pp |
| 2019 | 40.7% | $1.27 Billion | $3.11 Billion | $1.63 Billion | $364.49 Million | ▲ +8.5 pp |
| 2018 | 32.2% | $888.52 Million | $2.76 Billion | $1.23 Billion | $345.49 Million | ▲ +7.4 pp |
| 2017 | 24.9% | $674.33 Million | $2.71 Billion | $968.28 Million | $293.95 Million | ▼ -1.3 pp |
| 2016 | 26.1% | $490.66 Million | $1.88 Billion | $748.07 Million | $257.41 Million | ▼ -38.4 pp |
| 2015 | 64.5% | $1.03 Billion | $1.60 Billion | $1.26 Billion | $226.64 Million | ▲ +6.2 pp |
| 2014 | 58.3% | $799.04 Million | $1.37 Billion | $1.02 Billion | $216.80 Million | ▲ +7.3 pp |
| 2013 | 51.0% | $660.59 Million | $1.30 Billion | $864.62 Million | $204.03 Million | ▲ +18.9 pp |
| 2012 | 32.1% | $360.03 Million | $1.12 Billion | $551.57 Million | $191.54 Million | ▼ -43.8 pp |
| 2011 | 75.9% | $146.26 Million | $192.79 Million | $199.13 Million | $52.87 Million | ▲ +28.3 pp |
| 2010 | 47.5% | $14.52 Million | $30.55 Million | $74.46 Million | $59.94 Million | ▲ +16.9 pp |
| 2009 | 30.6% | $-22.29 Million | $-72.83 Million | $36.95 Million | $59.24 Million | ▼ -108.8 pp |
| 2008 | 139.4% | $-129.49 Million | $-92.88 Million | $44.00 Million | $173.49 Million | ▼ -4.7 pp |
| 2007 | 144.1% | $79.23 Million | $54.99 Million | $116.09 Million | $36.86 Million | ▲ +178.7 pp |
| 2006 | -34.6% | $61.04 Million | $-176.30 Million | $91.56 Million | $30.52 Million | ▼ -27.8 pp |
| 2005 | -6.8% | $8.05 Million | $-118.25 Million | $31.38 Million | $23.34 Million | — |